Altamira Therapeutics Ltd (CYTO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2000 | 06-2000 | 03-2000 | 12-1999 | 09-1999 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -21,210 | -4,540 | -1,960 | 720 | -530 |
| Depreciation Amortization | 670 | 470 | 220 | 1,050 | 780 |
| Other Working Capital | -580 | -1,170 | -2,000 | -3,760 | -5,110 |
| Other Operating Activity | 13,160 | 10 | -30 | -1,880 | -1,920 |
| Operating Cash Flow | $-7,960 | $-5,230 | $-3,770 | $-3,870 | $-6,780 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -600 | -440 | 40 | 190 | 3,440 |
| Net Acquisitions | 0 | 0 | 0 | 550 | 550 |
| Other Investing Activity | 1,590 | 0 | 0 | 1,990 | -2,360 |
| Investing Cash Flow | $990 | $-440 | $40 | $2,730 | $1,630 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 10,350 | 5,340 | 5,110 | 8,930 | 8,790 |
| Financing Cash Flow | $10,350 | $5,340 | $5,110 | $8,930 | $8,790 |
| Beginning Cash Position | 10,800 | 10,800 | 10,800 | 3,010 | 3,010 |
| End Cash Position | 14,170 | 10,460 | 12,180 | 10,800 | 6,660 |
| Net Cash Flow | $3,370 | $-330 | $1,380 | $7,780 | $3,640 |
| Free Cash Flow | |||||
| Operating Cash Flow | -7,960 | -5,230 | -3,770 | -3,870 | -6,780 |
| Free Cash Flow | -7,960 | -5,230 | -3,770 | -3,870 | -6,780 |